Company intelligence / Profile preview

QOL Technologies Ltd

United Kingdom

Ownership: Private
Development stage: Other

Overview

QOL Technologies Ltd's questionnaires are validated, culturally adapted into over 300 languages, and widely used for assessing quality of life and asthma control in clinical research; all are distributed/maintained through Mapi Research Trust. The company has transitioned some management/distribution roles but remains actively involved in tool development and consultancy

Therapeutic areas: ImmunologyPulmonology
Modalities: Non-pharmacological therapy (questionnaire/assessment tools)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Mapi Research Trust (distribution, management, and e-platform adaptation of questionnaires)ICON Language Services (exclusive translator/validation partner)

Beyond the preview

Go deeper on QOL Technologies Ltd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QOL Technologies Ltd.

Explore the full profile